Title : Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients.

Pub. Date : 2021 Jun 12

PMID : 34118937






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients. Nateglinide melatonin receptor 1B Homo sapiens
2 Genetic polymorphisms in the MTNR1B gene is associated with type 2 diabetes mellitus (T2DM); however, there is no evidence about its impact on the therapeutic efficacy of nateglinide. Nateglinide melatonin receptor 1B Homo sapiens
3 This prospective case-control study was designed to investigate the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating T2DM. Nateglinide melatonin receptor 1B Homo sapiens
4 MTNR1B rs10830963 polymorphism was associated with the therapeutic efficacy of nateglinide in T2DM patients. Nateglinide melatonin receptor 1B Homo sapiens